History of the LMB
Since its origin in 1947, the LMB has made many key scientific advances and, where appropriate, our discoveries and inventions have been commercialised and form the basis of several biotechnology companies, new therapeutics and medical advances.
2024
Spin‑out
TRIMTECH Therapeutics formed to advance targeted protein degradation therapies
2023
Spin‑out
Sortera Bio formed to realise therapeutic potential of deep screening technology
2023
Spin‑out
RNAvate formed to develop novel RNA medicines
2022
Spin‑out
Constructive Bio formed to develop DNA assembly and genome reprogramming technology
2018
Spin‑out
PepGen formed to develop cell penetrating peptides for the treatment of rare genetic disorders
2018
Spin‑out
Inflectis Bioscience founded to develop multifunctional brain-penetrant therapies for neurological diseases
2012
Technology
RELION computer programme developed for single-particle reconstruction of cryo-EM data
2009
Spin‑out
Bicycle Therapeutics formed to develop novel therapeutic platform
2008
Science
β-adrenergic receptor structure determined

2007
Spin‑out
Heptares Therapeutics formed to discover new medicines targeting G protein-coupled receptors
2002
Science
Molecular mechanism of antibody mutation uncovered
2000
Spin‑out
Domantis formed to develop human single domain antibody therapies
1999
Spin‑out
Gendaq launched to develop gene regulation technology using zinc finger DNA binding proteins
1998
Science
C. elegans is the first animal to have its genome sequenced

1997
Science
Identification of major component of filamentous lesions found in Parkinson’s disease

1994
Spin‑out
RiboTargets founded to develop structure-based antibacterial and anticancer therapeutics
1990
Technology
Phage display of antibody fragments technique developed
1989
Spin‑out
Cambridge Antibody Technology formed to develop antibody therapeutics
1988
Technology
First patient treated with humanised antibody, Campath-1
1987
Technology
Commercial production of MRC confocal microscope
1986
Science
C. elegans is the first animal to have its entire nervous system mapped

1985
Science
Zinc finger DNA-binding motif proposed

1984
Spin‑out
Somatogen founded to produce artificial blood
1983
Science
Embryonic cell lineage of C. elegans unravelled
1980
Spin‑out
Celltech founded to utilise monoclonal antibody technology
1976
Science
First computerised model of an enzymatic reaction
1975
Technology
Monoclonal antibody methodology invented
1975
Science
First 3D structure of a membrane protein, bacteriorhodopsin

1972
Science
Asymmetric lipid bilayer structure for biological membranes proposed
1972
Science
Signal peptide sequence which directs protein secretion discovered
1971
Science
Precursor tRNA molecules found and discovery of catalytic RNA
1967
Science
First mutant of nematode worm, C. elegans, produced

1962
Building
Original LMB building opened

1961
Science
Demonstration of the triplet nature of the genetic code [1]
1957
Science
Single amino acid change causes sickle cell anaemia [1]
1953
Science
Sliding filament model for muscle contraction proposed [1]

1951
Science
First full chemical sequence of a protein, insulin, deduced [2]
1947
Building
MRC ‘Unit for Research on the Molecular Structure of Biological Systems’ established

Footnote:
- Research conducted in the MRC Unit for Research on the Molecular Structure of Biological Systems located within the University of Cambridge.
- Research conducted in the University of Cambridge Department of Biochemistry, while Sanger was a member of the Extended Staff of the Medical Research Council.


















